{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T16:48:06Z","timestamp":1768322886826,"version":"3.49.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T00:00:00Z","timestamp":1530835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Fundaci\u00f3n P\u00fablica Andaluza para la Gesti\u00f3n de la Investigaci\u00f3n","award":["RD16\/0025\/0020-ISCIII-FEDER"],"award-info":[{"award-number":["RD16\/0025\/0020-ISCIII-FEDER"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,7,13]]},"DOI":"10.1093\/infdis\/jiy136","type":"journal-article","created":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T02:59:45Z","timestamp":1530673185000},"page":"624-632","source":"Crossref","is-referenced-by-count":53,"title":["Eradication of Hepatitis C Virus (HCV) Reduces Immune Activation, Microbial Translocation, and the HIV DNA Level in HIV\/HCV-Coinfected Patients"],"prefix":"10.1093","volume":"218","author":[{"given":"Luis F","family":"L\u00f3pez-Cort\u00e9s","sequence":"first","affiliation":[{"name":"Enfermedades Infecciosas, Microbiolog\u00eda Cl\u00ednica y Medicina Preventiva, Instituto de Biomedicina de Sevilla\/Hospital Universitario Virgen del Roc\u00edo\/CSIC\/Universidad de Sevilla, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Trujillo-Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Enfermedades Infecciosas, Microbiolog\u00eda Cl\u00ednica y Medicina Preventiva, Instituto de Biomedicina de Sevilla\/Hospital Universitario Virgen del Roc\u00edo\/CSIC\/Universidad de Sevilla, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"B\u00e1ez-Palomo","sequence":"additional","affiliation":[{"name":"Enfermedades Infecciosas, Microbiolog\u00eda Cl\u00ednica y Medicina Preventiva, Instituto de Biomedicina de Sevilla\/Hospital Universitario Virgen del Roc\u00edo\/CSIC\/Universidad de Sevilla, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar J","family":"Benmarzouk-Hidalgo","sequence":"additional","affiliation":[{"name":"Enfermedades Infecciosas, Microbiolog\u00eda Cl\u00ednica y Medicina Preventiva, Instituto de Biomedicina de Sevilla\/Hospital Universitario Virgen del Roc\u00edo\/CSIC\/Universidad de Sevilla, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Dominguez-Molina","sequence":"additional","affiliation":[{"name":"Enfermedades Infecciosas, Microbiolog\u00eda Cl\u00ednica y Medicina Preventiva, Instituto de Biomedicina de Sevilla\/Hospital Universitario Virgen del Roc\u00edo\/CSIC\/Universidad de Sevilla, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusnelkis","family":"Milan\u00e9s-Guisado","sequence":"additional","affiliation":[{"name":"Enfermedades Infecciosas, Microbiolog\u00eda Cl\u00ednica y Medicina Preventiva, Instituto de Biomedicina de Sevilla\/Hospital Universitario Virgen del Roc\u00edo\/CSIC\/Universidad de Sevilla, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuria","family":"Espinosa","sequence":"additional","affiliation":[{"name":"Enfermedades Infecciosas, Microbiolog\u00eda Cl\u00ednica y Medicina Preventiva, Instituto de Biomedicina de Sevilla\/Hospital Universitario Virgen del Roc\u00edo\/CSIC\/Universidad de Sevilla, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pompeyo","family":"Viciana","sequence":"additional","affiliation":[{"name":"Enfermedades Infecciosas, Microbiolog\u00eda Cl\u00ednica y Medicina Preventiva, Instituto de Biomedicina de Sevilla\/Hospital Universitario Virgen del Roc\u00edo\/CSIC\/Universidad de Sevilla, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Guti\u00e9rrez-Valencia","sequence":"additional","affiliation":[{"name":"Enfermedades Infecciosas, Microbiolog\u00eda Cl\u00ednica y Medicina Preventiva, Instituto de Biomedicina de Sevilla\/Hospital Universitario Virgen del Roc\u00edo\/CSIC\/Universidad de Sevilla, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,7,6]]},"reference":[{"key":"key\n\t\t\t\t20180713113045_CIT0001","first-page":"1287","article-title":"Rising mortality associated with hepatitis C virus in the United States, 2003\u20132013","volume":"62","author":"Ly","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180713113045_CIT0002","first-page":"748","article-title":"Higher all-cause hospitalization among patients with chronic hepatitis C: the Chronic Hepatitis Cohort Study (CHeCS), 2006-2013","volume":"23","author":"Teshale","year":"2016","journal-title":"J Viral Hepat"},{"key":"key\n\t\t\t\t20180713113045_CIT0003","first-page":"19","article-title":"Achieving sustained virologic response in hepatitis C: a systematic review of the clinical, economic and quality of life benefits","volume":"15","author":"Smith-Palmer","year":"2015","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20180713113045_CIT0004","first-page":"687","article-title":"Viral eradication reduces all-cause mortality, including non-liver-related disease, in patients with progressive hepatitis C virus-related fibrosis","volume":"32","author":"Tada","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t20180713113045_CIT0005","first-page":"730","article-title":"Long-term treatment outcomes of patients infected with hepatitis C virus: a systematic review and meta-analysis of the survival benefit of achieving a sustained virological response","volume":"61","author":"Simmons","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180713113045_CIT0006","author":"Plan estrat\u00e9gico para el abordaje de la hepatitis C en el Sistema Nacional de Salud"},{"key":"key\n\t\t\t\t20180713113045_CIT0007","first-page":"78","article-title":"HIV-associated chronic immune activation","volume":"254","author":"Paiardini","year":"2013","journal-title":"Immunol Rev"},{"key":"key\n\t\t\t\t20180713113045_CIT0008","first-page":"447","article-title":"Immune exhaustion occurs concomitantly with immune activation and decrease in regulatory T cells in viremic chronically HIV-1-infected patients","volume":"54","author":"Sachdeva","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20180713113045_CIT0009","first-page":"21","article-title":"Understanding and controlling chronic immune activation in the HIV-infected patients suppressed on combination antiretroviral therapy","volume":"10","author":"Taiwo","year":"2013","journal-title":"Curr HIV\/AIDS Rep"},{"key":"key\n\t\t\t\t20180713113045_CIT0010","first-page":"1387","article-title":"Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996\u20132006: collaborative analysis of 13 HIV cohort studies","volume":"50","author":"Antiretroviral Therapy Cohort Collaboration","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180713113045_CIT0011","first-page":"241","article-title":"Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration","volume":"384","author":"Smith","year":"2014","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180713113045_CIT0012","first-page":"20","article-title":"Inflammatory co-morbidities in HIV+ individuals: learning lessons from healthy ageing","volume":"11","author":"Hearps","year":"2014","journal-title":"Curr HIV\/AIDS Rep"},{"key":"key\n\t\t\t\t20180713113045_CIT0013","first-page":"533","article-title":"Serious non-AIDS events: therapeutic targets of immune activation and chronic inflammation in HIV infection","volume":"76","author":"Hsu","year":"2016","journal-title":"Drugs"},{"key":"key\n\t\t\t\t20180713113045_CIT0014","first-page":"2099","article-title":"Association of immune-activation and senescence markers with non-AIDS-defining comorbidities in HIV-suppressed patients","volume":"29","author":"Duffau","year":"2015","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180713113045_CIT0015","first-page":"191","article-title":"HIV infection and immune activation: the role of coinfections","volume":"11","author":"Boulougoura","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"key":"key\n\t\t\t\t20180713113045_CIT0016","first-page":"1297","article-title":"Immune activation throughout a boosted darunavir monotherapy simplification strategy","volume":"20","author":"BenMarzouk-Hidalgo","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180713113045_CIT0017","first-page":"11407","article-title":"High levels of chronic immune activation in the T-cell compartments of patients coinfected with hepatitis C virus and human immunodeficiency virus type 1 and on highly active antiretroviral therapy are reverted by alpha interferon and ribavirin treatment","volume":"83","author":"Gonzalez","year":"2009","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20180713113045_CIT0018","first-page":"e59302","article-title":"Complementary role of HCV and HIV in T-cell activation and exhaustion in HIV\/HCV coinfection","volume":"8","author":"Feuth","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180713113045_CIT0019","first-page":"232","article-title":"Characterization of CD4\u207a T-cell immune activation and interleukin 10 levels among HIV, hepatitis C virus, and HIV\/HCV-coinfected patients","volume":"64","author":"Hodowanec","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20180713113045_CIT0020","first-page":"1879","article-title":"Chronic immune activation and decreased CD4 cell counts associated with hepatitis C infection in HIV-1 natural viral suppressors","volume":"26","author":"Sajadi","year":"2012","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180713113045_CIT0021","first-page":"2381","article-title":"Influence of hepatitis C virus coinfection on CD4\u207a T cells of HIV-infected patients receiving HAART","volume":"28","author":"Shmagel","year":"2014","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180713113045_CIT0022","first-page":"e0119568","article-title":"Immune activation response in chronic HIV-infected patients: influence of hepatitis C virus coinfection","volume":"10","author":"M\u00e1rquez","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180713113045_CIT0023","first-page":"969","article-title":"The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection","volume":"45","author":"Vergara","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180713113045_CIT0024","first-page":"1177","article-title":"Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection","volume":"199","author":"Jiang","year":"2009","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180713113045_CIT0025","first-page":"201","article-title":"Cellular HIV reservoir replenishment is not affected by blip or intermittent viremia episodes during darunavir\/ritonavir monotherapy","volume":"28","author":"Torres-Cornejo","year":"2014","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180713113045_CIT0026","first-page":"728","article-title":"Sustained virological response to interferon plus ribavirin reduces non-liver-related mortality in patients coinfected with HIV and hepatitis C virus","volume":"55","author":"Berenguer","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180713113045_CIT0027","first-page":"1646","article-title":"Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV\/hepatitis C virus-coinfected patients with compensated cirrhosis","volume":"56","author":"Mira","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180713113045_CIT0028","first-page":"1511","article-title":"Incidence and predictors of cardiovascular disease, chronic kidney disease, and diabetes in HIV\/HCV-coinfected patients who achieved sustained virological response","volume":"35","author":"Leone","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20180713113045_CIT0029","first-page":"94","article-title":"CD4 and CD4\/CD8 ratio progression in HIV-HCV infected patients after achievement of SVR","volume":"81","author":"Saracino","year":"2016","journal-title":"J Clin Virol"},{"key":"key\n\t\t\t\t20180713113045_CIT0030","first-page":"344","article-title":"Eradication of hepatitis C virus and non-liver-related non-acquired immune deficiency syndrome-related events in human immunodeficiency virus\/hepatitis C virus coinfection","volume":"66","author":"Berenguer","year":"2017","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20180713113045_CIT0031","first-page":"326","article-title":"Immune activation and HIV persistence: implications for curative approaches to HIV infection","volume":"254","author":"Klatt","year":"2013","journal-title":"Immunol Rev"},{"key":"key\n\t\t\t\t20180713113045_CIT0032","first-page":"1438","article-title":"During hepatitis C virus (HCV) infection and HCV-HIV coinfection, an elevated plasma level of autotaxin is associated with lysophosphatidic acid and markers of immune activation that normalize during interferon-free HCV therapy","volume":"214","author":"Kostadinova","year":"2016","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180713113045_CIT0033","first-page":"e101","article-title":"Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals","volume":"40","author":"Antonucci","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180713113045_CIT0034","first-page":"1857","article-title":"Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy","volume":"24","author":"Potter","year":"2010","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180713113045_CIT0035","first-page":"715","article-title":"Effect of hepatitis C virus on immunological and virological responses in HIV-infected patients initiating highly active antiretroviral therapy: a meta-analysis","volume":"20","author":"Tsiara","year":"2013","journal-title":"J Viral Hepat"},{"key":"key\n\t\t\t\t20180713113045_CIT0036","first-page":"1312","article-title":"Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recovery","volume":"58","author":"Engsig","year":"2014","journal-title":"Clin Infect Dis"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/218\/4\/624\/25160485\/jiy136.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T16:58:22Z","timestamp":1531501102000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/218\/4\/624\/5050122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,6]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,7,6]]},"published-print":{"date-parts":[[2018,7,13]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiy136","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,8,15]]},"published":{"date-parts":[[2018,7,6]]}}}